Amneal Pharmaceuticals Inc - Ordinary Shares - Class A

NYSE:AMRX  
3.19
-0.09 (-2.74%)
Debt Financing / Related

Amneal Pharmaceuticals Says Co's Unit Entered Into Certain Revolving Credit Agreement

Published: 06/02/2022 21:45 GMT
Amneal Pharmaceuticals Inc - Ordinary Shares - Class A (AMRX) - Amneal Pharmaceuticals - on June 2, Unit Entered Into Certain Revolving Credit Agreement.
Amneal Pharmaceuticals - Credit Agreement Refinanced Existing Credit Agreement With Replacement $350 Million Senior Secured Revolving Credit Facility.
Amneal Pharmaceuticals - Credit Agreement Allows Unit to Request Incremental Increase in Revolving Facility Commitments by Up to $150 Million.
Amneal Pharmaceuticals - Unit's New Revolving Credit Facility Matures on June 2, 2027.
Further Company Coverage: Amrxn